Reset filter

Patient experience survey (pain medicine) - summary form

Patient experience survey (pain medicine) - summary form

ANZCA Strategic Plan 2018-2022

The ANZCA Strategic Plan 2018-2022 guides our college-wide business activity. It's the result of comprehensive consultation and engagement within the ANZCA community and beyond. 

EPA 4 Perioperative pain relief - EPA Review

EPA 4 Perioperative pain relief - EPA Review

Anaesthesia and smoking

Smokers are at increased risk of respiratory, cardiac and wound-related complications following surgery.

Find out more

Mortality Sub-committee

The Mortality Sub-committee was developed as a collaboration between the chairs of established anaesthetic mortality committees in Australia, under the auspices of ANZCA. The group is chaired by Dr Simon Jenkins, and includes the chairs of all established anaesthetic mortality...

Find out more

Propofol anaphylaxis

ANZCA has been notified of an episode of life-threatening anaphylaxis, most likely triggered by propofol, in a previously well 12 year-old boy with no allergy history. Propofol anaphylaxis is extremely rare but possible.

Find out more

Ventolin metered dose inhalers (AU)

Important information on changes to the design of Salbutamol (Ventolin) metered dose inhalers (MDIs/‘puffers’) in Australia.

Find out more

Neuroanaesthesia SIG

The Neuroanaesthesia SIG exists to foster interest in matters relating to the perioperative care and anaesthesia of patients with intracranial and spinal pathology. This includes the application of basic and translational science relevant to clinical anaesthesia.

Find out more

New Zealand recall: CareSens KetoSens Test Strip – specific batch returns false readings

Recall in New Zealand of CareSens KetoSens Test Strips batch UJ03PBXNG, which give false (too high) readings of patient blood ketones.

Find out more

Reg 27 - Performance assessment of anaesthetists and pain medicine physicians

First  < Prev   ... 31 32 33 34 35 36 37 38 39 40 ...   Next >  Last Pages: 37 of 132